About RMI Laboratories
RMI Laboratories is a Healthcare company based in North Wales (United States) founded in 2009, and was acquired by Frontage Laboratories in November 2019. ADME and DMPK services are provided through mass spectrometry techniques. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its competitors include ReveraGen and BioQual.
Company details
RMI Laboratories is a CRO offering in-vitro and in-vivo services for pharmaceutical and biotechnology companies. They specialise in offering ADME and DMPK services through their expertise in mass spectrometry-based techniques. The companies founders have earlier worked with NIH, USDA and Merck in areas of mass spectrometry, drug metabolism, pharmacokinetics and metabolite identification. Their services include discovery quantitation (HRMS and PK analysis), metabolite identification (early discovery soft spot analysis, late discovery cross-species comparison, preclinical animal radiolabelled mass balance studies), combination assays, biologics services (analysis of peptides, proteins and antibodies), and GLP quantitation (for preclinical and clinical studies).
- Headquarters North Wales, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website rmilaboratories.com
- Social LinkedIn
- Acquired by Frontage Laboratories (Nov 2019)
- Investors
- Acquired byFrontage Laboratories
(Nov 2019)
Investors in RMI Laboratories
RMI Laboratories has secured backing from 1 investor. Prominent investors backing the company include Frontage Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early drug development services are provided for pharma firms. | 2001 | frontagelab.com | Exton, United States |
Investor details for RMI Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of RMI Laboratories
2 dated milestones of RMI Laboratories across 10 years, from founding to its latest funding, stage changes and deals.
- Founded RMI Laboratories is founded.
- Exit Acquired by Frontage Laboratories.
Competitors of RMI Laboratories
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| reveragen.com | 2008 | Rockville, United States | Steroids for Duchenne muscular dystrophy treatment are developed. | |||
| bioqual.com | 1981 | Rockville, United States | 193 | Contract research on infectious disease models is conducted. |
Detailed competitors of RMI Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as RMI Laboratories (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Rmi Laboratories
Complete news archive for RMI Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RMI Laboratories
RMI Laboratories was founded in 2009.
RMI Laboratories is headquartered in North Wales, United States. It is registered at North Wales, Pennsylvania, United States.
RMI Laboratories is a CRO offering in-vitro and in-vivo services for pharmaceutical and biotechnology companies. They specialise in offering ADME and DMPK services through their expertise in mass spectrometry-based techniques. The companies founders have earlier worked with NIH, USDA and Merck in areas of mass spectrometry, drug metabolism, pharmacokinetics and metabolite identification. Their services include discovery quantitation (HRMS and PK analysis), metabolite identification (early discovery soft spot analysis, late discovery cross-species comparison, preclinical animal radiolabelled mass balance studies), combination assays, biologics services (analysis of peptides, proteins and antibodies), and GLP quantitation (for preclinical and clinical studies).
RMI Laboratories has 1 investor. Key investors include Frontage Laboratories.
Yes. RMI Laboratories was acquired by Frontage Laboratories in November 2019.